Penn Capital Management Company, LLC Collegium Pharmaceutical, Inc Transaction History

Penn Capital Management Company, LLC

  • $983 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$31.23 - $40.91 $2.23 Million - $2.92 Million
-71,258 Reduced 22.57%
244,516 $9.49 Million
Q4 2023

Feb 14, 2024
BUY
$21.16 - $30.8 $6.68 Million - $9.73 Million
315,774 New
315,774 $9.72 Million
Q2 2023

Aug 14, 2023
BUY
$21.06 - $24.0 $2.22 Million - $2.53 Million
105,359 New
105,359 $2.26 Million

Others Institutions Holding COLL

# of Institutions
248
Shares Held
37.5M
Call Options Held
100K
Put Options Held
10K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.04B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Penn Capital Management Company, LLC Portfolio

Follow Penn Capital Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Capital Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email